• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 Medical Services Advisory Committee (MSAC) Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
2013 Medical Services Advisory Committee (MSAC) Codependent with PBAC- intravesical injection of botulinum toxin (Botox) into the bladder wall for urinary incontinence due to idiopathic overactive bladder
2013 Medical Services Advisory Committee (MSAC) Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent)
2013 Medical Services Advisory Committee (MSAC) Insertion, replacement, or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild, moderate or severe chronic heart failure (NYHA II, III or IV)
2013 Medical Services Advisory Committee (MSAC) Single balloon enteroscopy
2013 HTA Unit, University of Calgary Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2013 Institute for Clinical and Economic Review (ICER) Cardiac nuclear imaging
2013 Institute for Clinical and Economic Review (ICER) Cervical spinal fusion for degenerative disc disease
2013 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
2013 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Systematic review on needs for medical devices for older people
2013 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Breast prosthesis implantation for reconstructive and cosmetic surgery: a rapid review
2013 Institute of Health Economics (IHE) Islet transplantation for the treatment of type 1 diabetes [update]
2013 Haute Autorite de sante (HAS) [Laser treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia]
2013 Haute Autorite de sante (HAS) [Clinical utility of the measurement of vitamin D]
2013 Haute Autorite de sante (HAS) [Bone substitutes]
2013 Haute Autorite de sante (HAS) [Bypass prostheses]
2013 Haute Autorite de sante (HAS) [Spinal implants (interbody cage, interspinous process spacer, spacer, lumbosacral support implant)]
2013 Malaysian Health Technology Assessment (MaHTAS) Intraocular lens (IOL) implantation and opacification – an update
2013 Malaysian Health Technology Assessment (MaHTAS) Collagen for anti aging treatment, enhance cell regeneration and boosting the immune system
2013 Malaysian Health Technology Assessment (MaHTAS) Negative pressure wound therapy (Renasys Go Console Package)
2013 Malaysian Health Technology Assessment (MaHTAS) Photodynamic therapy for cancer treatment – an update
2013 Malaysian Health Technology Assessment (MaHTAS) Placenta for cosmetic purpose and cell regeneration
2013 Malaysian Health Technology Assessment (MaHTAS) Namyang Ketonia – ketogenic diet treatment for epilepsy
2013 Malaysian Health Technology Assessment (MaHTAS) Epidermal Growth Factor Receptor (EGFR) mutation test for patients with Non-Small Cell Lung Cancer (NSCLC)
2013 Malaysian Health Technology Assessment (MaHTAS) Colostrum for cosmetic purpose and cell regeneration
2013 Malaysian Health Technology Assessment (MaHTAS) Chlorthalidone for hypertensive patients
2013 Malaysian Health Technology Assessment (MaHTAS) Avemar granulate as dietary food / special purpose food for cancer
2013 Malaysian Health Technology Assessment (MaHTAS) Water birth
2013 Malaysian Health Technology Assessment (MaHTAS) Transcranial Doppler (TCD) ultrasound and cerebral computed tomography perfusion (CTP) for aneurysmal subarachnoid haemorrhage (SAH)
2013 Malaysian Health Technology Assessment (MaHTAS) X Collar versus conventional cervical collar
2013 Malaysian Health Technology Assessment (MaHTAS) Ultraviolet Germicidal Irradiation (UVGI) indoor purifier – an update
2013 Malaysian Health Technology Assessment (MaHTAS) Symptoms checker
2013 Malaysian Health Technology Assessment (MaHTAS) QuantiFERON® -TB Gold
2013 Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma for treatment of osteoarthritis
2013 Malaysian Health Technology Assessment (MaHTAS) Autologous peripheral blood stem cells for articular cartilage repair
2013 Malaysian Health Technology Assessment (MaHTAS) NH2 Drug Lab (DRUGKOP)
2013 Malaysian Health Technology Assessment (MaHTAS) Mobile phone with portable electrocardiogram (ECG) device
2013 Malaysian Health Technology Assessment (MaHTAS) INJEX (needle free drug delivery system)
2013 Malaysian Health Technology Assessment (MaHTAS) HAIFU® Model- Jc focused ultrasound tumor therapeutic system - an update
2013 Malaysian Health Technology Assessment (MaHTAS) EndostatTM antimicrobial treatment
2013 New Zealand National Health Committee (NHC) Renal denervation – technology note
2013 New Zealand National Health Committee (NHC) Percutaneous interventions for mitral regurgitation - technology Note
2013 New Zealand National Health Committee (NHC) Left atrial appendage – technology note
2013 New Zealand National Health Committee (NHC) New and emerging cardiac technologies in Australian and New Zealand public health service over the next decade
2013 New Zealand National Health Committee (NHC) Ventilation tubes: an opportunity for better targeting - technology note
2013 Basque Office for Health Technology Assessment (OSTEBA) [Adaptation and assessment of an online research methodology training course for nurses]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Map on shared resources in health technology assessment]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Enhancing the quality of information on colorectal and prostate cancer in the population cancer register of the Basque Country (RCE) and bibliographical review]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of bubble humidification systems in low-flow oxygen therapy. Systematic review and cost analysis]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Evaluating the implementation of diagnostic telemedicine in the field of dermatology]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Usefulness of dietary treatments in Lysine metabolic disorders]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Lipid metabolism disorders: review of the indications of fat free dietetic products and nutritional alternatives with regularly consumed foodstuffs]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Economic evaluation of a telemonitoring intervention from primary care in home care patients with cardiac insufficiency and/or chronic bronchial disorders: Cost-effectiveness analysis, TELBIL study]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation and impact of a primary care-based telemonitoring intervention in home care patients with heart failure or chronic lung disease. Randomised controlled trial. The TELBIL study]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Individualised multidisciplinary care programme in frail patients (PAMI)]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Alternatives to short stay psychiatric hospitalisation. Intensive ambulatory monitoring programmes]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Quality of life of stroke patients and their caregivers. Prognosis and results of rehabilitating treatment]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Redesigning maternal education: proposal for a framework to draw up an education programme for health and effective birth preparation focused on the needs of women]
2013 Basque Office for Health Technology Assessment (OSTEBA) [A study of the use of clinical practice guidelines in specialized care: barriers and facilitators to implementation]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Design of an interaction protocol between Primary Care and Hospitals to improve early detection and monitoring of patients with multiple sclerosis]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Terminal care: systematic review of organisational models in palliative care and survey of health professionals regarding the situation of palliative care in a region of the Basque Country]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Results of the perinatal care of very premature children in the health system of the Basque Country]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the status, systematic review and validation of a diagnostic algorithm for pulmonary thromboembolism (PTE) in the hospital emergency services of the Basque Health Service]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Hemoperfusion with polymyxin-B for the treatment of sepsis of abdominal origin by gram negative microorganisms]
2013 Basque Office for Health Technology Assessment (OSTEBA) [CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2013 Andalusian Health Technology Assessment Area (AETSA) [Recommendations for the proper use of inverted shoulder prosthesis]
2013 Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis. Short version]
2013 Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis. Fast version]
2013 Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis]
2013 Andalusian Health Technology Assessment Area (AETSA) [Guide for the preparation of drug evaluation reports]
2013 Andalusian Health Technology Assessment Area (AETSA) [Fidaxomicin for the treatment of clostridium difficile infection]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of long-term lowering of blood pressure to levels in the lower normal range in patients with diabetes mellitus - Rapid report]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Decitabine - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Crizotinib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin/metformin (drug combination) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brentuximab Vedotin - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pixantrone - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dapagliflozin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Aflibercept - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ingenol mebutate - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fidaxomicin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Abiraterone acetate (New therapeutic indication) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A12-16 Saxagliptin/metformin]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A12-15 Crizotinib]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pilot study: analytic hierarchy process in the indication "major depression"]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A12-18 (dapagliflozin)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Aflibercept (Zaltrap) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-05 (fidaxomicin)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vandetanib (second assessment) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lixisenatide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-06 (Abiraterone acetate [New therapeutic indication])]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in oesophagus cancer]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colestilan - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sitagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sitagliptin/Metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]